[PDF] Top 20 Emerging treatment options for psoriasis

... The Center for Dermatology Research is supported by an unre- stricted educational grant from Galderma Laboratories, LP. SRF is a consultant and speaker for Galderma, Stiefel/Glaxo- SmithKline, Abbott Labs, Warner ... See full document

... no treatment-related serious AEsadverse events was reported in ALX-0761 (M1095)- – exposed ...showed treatment-emergent anti- drug antibody responses with no effect on ALX-0761 (M1095) ...short-term ... See full document

... Biological therapies are an emerging treatment option for a range of disease in dermatology. Safety profiles to date have been promising with relatively few serious adverse outcomes. However, concerns ... See full document

... untreated eyes developed macular atrophy, and after 5 years, the prevalence was 96.3%. In eyes treated for mCNV, the area of macular atrophy increased significantly until the final evaluation. So, this confirms that CRA ... See full document

... therapeutic options outside of the normal treatment recommendations such as topical imiquimod, topical tazarotene, topical methotrexate, excimer light sources, and photodynamic therapy have been published ... See full document

... plaque psoriasis and have not speci fi cally investigated in isolated ...the treatment of psoriasis of the anogenital area with ...of treatment with ...the treatment of ... See full document

... Ecotoxicological effects of BACs have been demonstrated in a wide range of studies (Fry and Toone, 1981, Guillette et al., 1994, Folmar et al., 1996, Harries et al., 1996, Jobling et al., 1998, Jenkins et al., 2001, ... See full document

... The aims of maintenance therapy in lupus nephritis are consolidation of renal response achieved during induction therapy, prevention of disease flares, and prompt identification of disease relapse, ultimately leading to ... See full document

... initial-phase treatment is with rifampicin 10 mg/kg, moxifloxacin 400 mg, pyrazinamide, and ethambutol, while continuation-phase treatment is either twice-weekly rifapentine 15 mg/kg and moxifloxacin for 2 ... See full document

... radiation treatment, collimated charged-particle beams peaking at the desired tissue depth and stopping thereafter (Bragg ...tumor treatment with no exit dose beyond the tumor and theoretical sparing of ... See full document

... optional treatment for MGD, intraductal meibomian gland probing may also have some disadvan- tages, such as variable discomfort and orifice hemorrhage during the ... See full document

... is treatment with purine analogs (PAs), such as cladribine or pentostatin, which provide a high rate of long-lasting clinical ...various treatment strategies such as the combination of PA and anti-CD20 ... See full document

... FXS treatment development, this review details both completed clinical trials for the targeted and symptomatic treatment of FXS and introduces novel projects on the cusp of clinical trial ... See full document

... physician’s preferences with the titration regimen being our preferred regimen. Whatever the choice, the reality is that close to 60% of patients will have a relapse and discussions should include the possibility of RAI ... See full document

... For lack of specific etiology, all therapeutic options aim towards the resolution of the clinical symptoms and/or the healing of the esophageal mucosa. Unfortunately, EoE is considered to be a chronic disease and ... See full document

... Cetuximab has long been approved for KRAS wild-type colon cancer, which raises interest in studying this anti- body in BTC. A recently completed randomized Phase II trial (BINGO [A multicenter, randomized phase II trial ... See full document

... of treatment options, all with their own side effect profile, means that there is considerable value in being able to deter- mine a patient’s prognosis early in their disease process, and to direct their ... See full document

... of treatment at this point include adequate hydration and correction of electrolyte imbalances, management of an underlying disorder (ie, diabetes mellitus), and alleviation of the presenting symptoms, such as ... See full document

... and treatment of the initial bleeding episode was successful in 24 of 28 ...of treatment with rpFVIII, however, and all study patients achieved FVIII levels ... See full document

... maintenance treatment until week 52 sustained their clinical ...included treatment with the lower dose, higher body weight, failure to respond to at least one biologic agent, longer duration of ... See full document